An application or a request for the establishment of maximum residue limits (MRLs) shall be submitted to European Medicines Agency (EMA) electronically.
The particulars and documents accompanying an application or a request for the establishment of MRLs shall be presented in accordance with the requirements set out in the Annex.
However, with regard to requests for a ‘no MRL required’ classification for chemical-unlike biological substances, the particulars and documents shall be those specified in section I.7, first paragraph, points (a) to (e), of Annex I to Commission Regulation (EU) 2018/782 [Commission Regulation (EU) 2018/782 of 29 May 2018 establishing the methodological principles for the risk assessment and risk management recommendations referred to in Regulation (EC) No 470/2009 (OJ L 132, 30.5.2018, p. 5, ELI: https://data.europa.eu/eli/reg/2018/782/oj).].